FindTrial
Sign In

Clinical Study on the Efficacy and Safety of Yin-Yang Regulating Moxibustion in the Treatment of Obesity with Spleen Deficiency and Dampness Obstruction Syndrome

Clinical Study on the Efficacy and Safety of Yin-Yang Regulating Moxibustion in the Treatment of Obesity with Spleen Deficiency and Dampness Obstruction Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001754
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Control group:Diet and Exercise Therapy
Experimental group:Yin-Yang Conditioning Moxibustion + Diet and Exercise Therapy

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Obese patients aged 18-60 meeting both Western and Traditional Chinese Medicine diagnostic criteria: Western medicine diagnostic criteria according to the Guidelines for Obesity Diagnosis and Treatment (2024) issued by the National Health Commission: BMI =28 kg/m²; TCM diagnostic criteria based on Guidelines for Diagnosis and Treatment of Common Internal Diseases in TCM - Pattern Section for spleen deficiency and dampness obstruction pattern in qi-blood-body fluid disorders: manifested as obesity, soft muscle tone, fatigue, limb edema, and poor appetite; (2) No use of any hormonal medications or weight-loss drugs within the past month; (3) Signed informed consent form and voluntary participation in the study. All above criteria must be met for participation in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with endocrine diseases (e.g., polycystic ovary syndrome, Cushing's syndrome, hypothyroidism, etc.); (2) Poorly controlled hypertension; combined with diabetes mellitus or severe cardiovascular/cerebrovascular diseases; (3) Use of contraceptive medications, antibiotics, or probiotics within the past month; (4) History of bariatric surgery or weight-loss drug therapies; (5) Allergy to mugwort leaves or moxa smoke; (6) Poor compliance rendering inability to follow the treatment protocol. Patients meeting any of the above criteria will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
BMI;Analysis of Gut Microbiota;—

Secondary

MeasureTime frame
Waist circumference, weight, body fat percentage and basal metabolic rate;Four blood lipid indicators;Body Weight Impact on Quality of Life Scale;Chinese Medicine Clinical Symptom Scoring Scale;—

Countries

China

Contacts

Public ContactSong Aiqun

Hubei Provincial Hospital of Traditional Chinese Medicine

345855503@qq.com13307183015

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026